- Home
- BRBI vs NRC Comparison
BRBI vs NRC Comparison
Compare BRBI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRBI | NRC |
|---|---|---|
| Founded | 2009 | 1981 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 365.4M | 428.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BRBI | NRC |
|---|---|---|
| Price | $15.62 | $20.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.0K | ★ 68.2K |
| Earning Date | 02-10-2026 | 02-03-2026 |
| Dividend Yield | ★ 5.08% | 3.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.31 | ★ 0.71 |
| Revenue | N/A | ★ $139,102,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.80 | N/A |
| P/E Ratio | ★ $11.88 | $29.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.15 | $9.76 |
| 52 Week High | $67.01 | $22.79 |
Technical Indicators
Market Signals| Indicator | BRBI | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 62.25 | 51.75 |
| Support Level | $13.85 | $18.43 |
| Resistance Level | $14.55 | $22.79 |
| Average True Range (ATR) | 0.60 | 0.97 |
| MACD | 0.15 | -0.13 |
| Stochastic Oscillator | 89.78 | 38.53 |
Price Performance
Historical ComparisonAbout BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.